# A Study in Erectile Dysfunction

> **NCT01130532** · PHASE4 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 623 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** Tadalafil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01130532
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 623 (ACTUAL)
- **Last updated:** 2013-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01130532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01130532, "A Study in Erectile Dysfunction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01130532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*